Blister Pack Pharmaceutical Products Market Size, Share, Growth, Analysis and Forecast 2032

What is the projected value for the Blister Pack Pharmaceutical Products Market during 2024 to 2032?

According to the report published by Zion Market Research, the global Blister Pack Pharmaceutical Products Market size was valued at USD 8.01 Billion in 2023 and is predicted to reach USD 17.26 Billion by the end of 2032. The market is expected to grow with a CAGR of 8.9% during the forecast period. The report analyzes the global Blister Pack Pharmaceutical Products Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Blister Pack Pharmaceutical Products industry.

Request Free Sample

Global Blister Pack Pharmaceutical Products Market: Overview

Blister packaging consists of polyvinyl chloride or polyethylene terephthalate plastic packaging. The rugged material utilized in blister packaging is ideal for diverse applications including toy production, the manufacturing of electronic equipment, and the packaging of pharmaceutical products. Blister packaging ensures product safety and protection. Moreover, it is cost-effective and the wider graphics area further boosts the sales footprint.

Global Blister Pack Pharmaceutical Products Market: Growth Factors

The steady demand from the pharma sector is one of the major factors driving the growth of the global blister pack pharmaceutical products market. Blister packaging is always a primary choice for pharmaceutical companies because of the convenience and benefits offered by monolayer and multilayer formats. Increasing expenditure on healthcare facilities coupled with the surging demand for the wide range of pharmaceutical drugs is inducing the companies to opt for outsourcing services through contract development. The manufacturing and contract developing organizations also facilitate services associated with active pharmaceutical production and product development along with packaging services.

A majority of pharmaceutical tablets and capsules are packed in blister packaging format. Furthermore, packaging formats like jars, bottles, and containers are also common in the pharmaceutical sector to store, seal, and pack tablets & capsules. Blister packaging, being a sustainable packaging solution, is adopted by a wide number of businesses. The ongoing technological developments and innovations in pharmaceutical packaging solutions will further augment the sales of blister pack pharmaceutical products. The growing preference for unit dosing and small pack sizes is likely to support the growth of the market. However, the unit dosage allows the protection of the primary product from the risk of being contaminated for a long period of time and also keeps the rest of the product secured and sealed from external contaminants.

Moreover, the leading market players are increasing their investments to boost the research and development activities in order to launch distinctive packaging solutions in the market. The prominent market leaders involved in the market are concentrating on forging strategic alliances along with launching sustainable and innovative blister pack pharmaceutical products to gain a competitive edge. Furthermore, the deployment and customization of new manufacturing techniques further enhance the quality and performance, which in turn is further likely to escalate the demand for blister pack pharmaceutical products in the forthcoming years.

Request Free Sample

Global Blister Pack Pharmaceutical Products Market: Segmentation

The global blister pack pharmaceutical products market can be segmented into end-user, technology, drug type, and region.

By end-user, the market can be segmented into veterinary drugs, nutraceuticals & supplements, and pharmaceuticals. The pharmaceutical segment accounts for the largest share in the global blister pack pharmaceutical products market due to its huge demand from packaging products like capsules and tablets.

By technology, the market can be segmented into thermoforming and cold forming technology. The thermoforming technology segment holds the largest share in the global blister pack pharmaceutical products market due to its capability to seal and pack a diverse range of pharmaceutical products at low manufacturing costs and faster speed.

By drug type, the market can be segmented into capsules and tablets.

Recent Developments:

• In September 2025, AptarGroup (US) introduced a smart blister pack equipped with IoT technology for real-time monitoring of medication adherence. This innovation addresses ongoing compliance challenges in healthcare and strengthens AptarGroup’s value proposition, supporting greater customer loyalty and market expansion.
• In August 2025, Amcor (AU) introduced a new line of eco-friendly blister packs to reduce plastic waste. The launch strengthens Amcor’s position in sustainable packaging and aligns with rising global demand for environmentally responsible solutions in the pharmaceutical sector.
• In June 2024, Keystone Folding Box introduced Push-Pak, a paperboard blister wallet for pharmaceutical tablets. The design features a simple push-through opening mechanism and a more compact blister layout, reducing overall package size while eliminating the need for complex opening instructions.

Blister Pack Pharmaceutical Products Market: Report Scope

Global Blister Pack Pharmaceutical Products Market: Regional analysis

North America accounts for the largest share in the global blister pack pharmaceutical products market due to the presence of prominent market leaders in the region. Moreover, the growing initiatives from the government to strengthen the healthcare infrastructure and associated services are likely to further promulgate the growth of the regional market in the forthcoming years.

Asia Pacific is anticipated to witness a significant growth rate during the forecast period due to the rapidly proliferating pharma sector in the region. Also, the ongoing technological advancements in the field of packaging products will further escalate the growth of the regional market.

Global Blister Pack Pharmaceutical Products Market: Competitive Players

Some of the significant players in the global blister pack pharmaceutical products market are

• Cadila Healthcare, etc.
• Sun Pharmaceutical Industries Ltd
• Merck
• Johnson & Johnson
• Allergan
• Novartis AG
• Roche Holding AG
• Sanofi
• GlaxoSmithKline plc
• Pfizer Inc.

Global Blister Pack Pharmaceutical Products Market: Segment Analysis

By drug type

• capsules
• tablets

By technology

• thermoforming
• cold forming technology

By end-user

• veterinary drugs
• nutraceuticals & supplements
• pharmaceuticals

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provide

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.